The new cell type, called ovoid cells, are ... Opening for a New Type of Drug for Alzheimer's Disease Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific ...

The possibility that Alzheimer’s disease diagnosis is associated with viruses, bacteria, fungi, and parasites has been postulated over the past three decades. (L-R) In green - herpes virus proteins.

Dementia is top of mind for Dr. Nathaniel Chin — not only because he’s the medical director for the Wisconsin Registry for Alzheimer’s Prevention but also because his father, Dr. Moe Chin ...

Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...

More than 6 million Americans have Alzheimer’s disease and related dementias, a number that is projected to double by 2060. The rise is attributed to several factors, many of them preventable ...

THEN IN 2019, JOE WAS DIAGNOSED WITH ALZHEIMER’S DISEASE. EVEN THOUGH WE WERE UPSET AND A LITTLE IN SHOCK. AND OKAY, WHAT DOES THIS MEAN? WE ASKED THE DOCTOR IMMEDIATELY. WE WANT TO GET INVOLVED ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers cellular inflammation and aging and is linked to Alzheimer's disease ...

Get in touch with us by email, phone, post or social media for more information on our local campaigns and services, dementia awareness sessions, and how you can get involved in our work. If you need ...

Our next Dementia Action Week will take place from 19 - 25 May 2025, where we will continue raise awareness of the importance of a timely and accurate diagnosis for people affected by dementia.

But now, a new study finds that taking these medications may lower your risk of developing a host of different health issues, including dementia. Of course, it isn't all positive. The scientists ...

This study maps proteomic changes in Alzheimer’s mouse models, identifying shared pathways with humans, amyloid-driven protein turnover, and proteome-transcriptome differences, offering insights ...